Literature DB >> 20452400

Characteristics of No-go-P300 component during somatosensory Go/No-go paradigms.

Hiroki Nakata1, Kiwako Sakamoto, Ryusuke Kakigi.   

Abstract

The present study investigated one of the characteristics of No-go-related brain activity during somatosensory Go/No-go paradigms, by manipulating the stimulus site and response hand. Somatosensory event-related potentials (ERPs) were recorded in ten right-handed subjects. Electrical stimulation was delivered to the second and fifth digit of one hand, and the subjects had to respond to a Go stimulus by pushing a button with the thumb contralateral to the stimulated side as quickly as possible. We focused on the peak amplitude and latency of Som-Go-P300 (P300 evoked by somatosensory Go stimuli) and Som-No-go-P300 (P300 evoked by somatosensory No-go stimuli) components. The amplitude of Som-No-go-P300, which is very similar to No-go-P300 components following visual and auditory stimulation, was significantly larger than that of Som-Go-P300 at fronto-central electrodes, indicating 'anteriorization' of the No-go-P300. The amplitude of Som-No-go-P300 was significantly larger in right than left hemispheres during right hand response conditions, but this difference was not found under left hand conditions. In addition, the difference in amplitude between Som-Go- and Som-No-go-P300, which is frequently described as 'the Go/No-go effect' on P300, was significant in the left hemisphere under right hand response conditions, whereas a significant effect was found in both the left and the right hemispheres under left hand response conditions. Our findings suggested that the anteriorization of No-go-P300 was independent of stimulus modalities such as visual, auditory, and somatosensory, and the amplitude of No-go-P300 and Go/No-go effects on P300 was affected by the response hand. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20452400     DOI: 10.1016/j.neulet.2010.05.002

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  The relationship between reaction time and response variability and somatosensory No-go potentials.

Authors:  Hiroki Nakata; Kiwako Sakamoto; Ryusuke Kakigi
Journal:  Eur J Appl Physiol       Date:  2011-04-26       Impact factor: 3.078

2.  Fast-ball sports experts depend on an inhibitory strategy to reprogram their movement timing.

Authors:  Hiroki Nakamoto; Sachi Ikudome; Kengo Yotani; Atsuo Maruyama; Shiro Mori
Journal:  Exp Brain Res       Date:  2013-05-10       Impact factor: 1.972

Review 3.  The integration of negative affect, pain and cognitive control in the cingulate cortex.

Authors:  Alexander J Shackman; Tim V Salomons; Heleen A Slagter; Andrew S Fox; Jameel J Winter; Richard J Davidson
Journal:  Nat Rev Neurosci       Date:  2011-03       Impact factor: 34.870

4.  Modality-specific improvements in sensory processing among baseball players.

Authors:  Koya Yamashiro; Yudai Yamazaki; Kanako Siiya; Koyuki Ikarashi; Yasuhiro Baba; Naofumi Otsuru; Hideaki Onishi; Daisuke Sato
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

5.  Identification of selection and inhibition components in a Go/NoGo task from EEG spectra using a machine learning classifier.

Authors:  Bambi L DeLaRosa; Jeffrey S Spence; Michael A Motes; Wing To; Sven Vanneste; Michael A Kraut; John Hart
Journal:  Brain Behav       Date:  2020-10-19       Impact factor: 2.708

6.  Modality differences in ERP components between somatosensory and auditory Go/No-go paradigms in prepubescent children.

Authors:  Hiroki Nakata; Miho Takezawa; Keita Kamijo; Manabu Shibasaki
Journal:  PLoS One       Date:  2021-11-08       Impact factor: 3.240

7.  Competition among the attentional networks due to resource reduction in Tibetan indigenous residents: evidence from event-related potentials.

Authors:  Delong Zhang; Xinjuan Zhang; Hailin Ma; Yan Wang; Huifang Ma; Ming Liu
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.